Chamomile

Summary

Chamomile (CHEMBL2108918) is a phase-3 clinical-stage unknown; indicated across 7 conditions including neonatal abstinence syndrome and generalized anxiety disorder.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Unknown
• Indications: 7 conditions
• Clinical trials: 15

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2108918
Name	Chamomile
Type	Unknown
Max phase	3

Also known as: 2Z4LRR776S, B2045, Blue chamomile flower, Chamomile, Chamomile flower, german, Chamomile flowers, Chamomile tea, Chamomile whole, Chamomilla, Chamomilla chamomilla flower, Chamomilla flower

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

7 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
neonatal abstinence syndrome	3	MONDO:0005566	EFO:0005799
generalized anxiety disorder	3	MONDO:0001942	EFO:1001892
gingivitis	3	MONDO:0002508	MONDO:0002508
stomatitis	2	MONDO:0004842	EFO:1001904
radiodermatitis	2	MONDO:0043771	MONDO:0043771
lichen planus, oral	1	MONDO:0043923	EFO:0008517
canker sore	1	MONDO:0005318	HP:0011107

Clinical trials

Total trials: 15.

Phase distribution

Phase	Trials
Not specified	11
PHASE4	1
PHASE2/PHASE3	1
PHASE2	1
PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00645983	PHASE4	COMPLETED	Chamomile Therapy for Generalized Anxiety
NCT07138391	PHASE2/PHASE3	NOT_YET_RECRUITING	Chamomile Gummies and Pediatric Dental Anxiety
NCT06214273	PHASE2	UNKNOWN	Low Level Diode Laser Versus Topical Chamomile in Management of Chemotherapy Induced Oral Mucositis
NCT03793634	PHASE1	UNKNOWN	Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus
NCT07092878	Not specified	RECRUITING	Effects of Chamomile With L-theanine Beverage Among Young Women Experiencing Primary Dysmenorrhea
NCT07515612	Not specified	RECRUITING	The Impact of Valerian and Chamomile on Children’s Anxiety in the Dental Clinic.
NCT00010933	Not specified	COMPLETED	Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities
NCT03477669	Not specified	TERMINATED	Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants
NCT03526081	Not specified	COMPLETED	Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides
NCT03605186	Not specified	UNKNOWN	Prevention of Oral Mucositis After Using Chamomile Oral Cryotherapy Versus Oral Cryotherapy in Pediatric Cancer Patients Receiving Chemotherapy.
NCT05006378	Not specified	COMPLETED	Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
NCT05272475	Not specified	COMPLETED	The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
NCT05696665	Not specified	UNKNOWN	Role of Saffron and Chamomile in the Management of Parkinson’s Disease
NCT06114797	Not specified	COMPLETED	Chamomile Effect on Xerostomia Associated With End-stage Renal Disease in Elderly
NCT06770166	Not specified	COMPLETED	The Effect of Chamomile on Healing After Tooth Extraction

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).